{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/XEN.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"XEN.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"XEN.AU\",,,,,undefined,":{"symbol":"XEN.AU","market":"AU","secType":"STK","nameCN":"XENITRA LIMITED","latestPrice":0.002,"timestamp":1789539120000,"preClose":0.0025,"halted":0,"volume":900000,"delay":0,"changeRate":-0.2,"nameEN":"XENITRA LIMITED","floatShares":3227708209,"shares":4694858828,"eps":-0.0015,"marketStatus":"未開盤","change":-0.0005,"latestTime":"09-16 16:12:00 AEST","open":0.002,"high":0.002,"low":0.002,"amount":1800,"amplitude":0,"askPrice":0.003,"askSize":3795843,"bidPrice":0.002,"bidSize":44330887,"shortable":3,"etf":0,"ttmEps":-0.0015,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"listingDate":1773925200000,"exchange":"ASX","adjPreClose":0.0025,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":1.3264499424320724,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"XEN.AU","preClose":0.003,"auctionPrice":0.003,"auctionVolume":300000,"auction":3,"marketStatus":"盘后竞价","timestamp":1788933600702}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"XEN.AU\",,,,,undefined,":{"symbol":"XEN.AU","floatShares":3227708209,"roa":"-52.11%","roe":"-378.25%","lyrEps":-0.0015,"volumeRatio":1.3264499424320724,"shares":4694858828,"dividePrice":0,"high":0.002,"amplitude":0,"preClose":0.0025,"low":0.002,"week52Low":0.002,"pbRate":"37.26","psRate":"0.46","week52High":0.004,"institutionHeld":0,"latestPrice":0.002,"committee":0.842256,"eps":-0.0015,"divideRate":0,"volume":900000,"delay":0,"ttmEps":-0.0015,"open":0.002,"prevYearClose":0.003,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.002,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.003},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XEN.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XEN.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XEN.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1176353737","title":"Xenitra與知名非處方藥企簽署1200萬澳元供貨協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1176353737","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176353737?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 09:58","pubTimestamp":1785117515,"startTime":"0","endTime":"0","summary":"据路透社7月27日消息，Xenitra Limited宣布达成一项价值1200万澳元的供货协议，合作方是一家领先的非处方药（OTC）制药企业。\n公司表示，已与康盛股份（Zhe Jiang Kangsheng Co., Ltd.）签署了一份为期三年的药品采购框架协议。所有金额均以澳元计。\nXenitra预计，首批商业订单将在本季度内启动执行，标志着双方合作正式进入实质性阶段。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0118","BK0139","BK0259","002418","BK7128","BK0151","XEN.AU","BK0014","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151205903","title":"Xenitra有限公司現已全資收購福康股份，並獲得運營非處方藥業務所需資產","url":"https://stock-news.laohu8.com/highlight/detail?id=1151205903","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151205903?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 07:22","pubTimestamp":1776208934,"startTime":"0","endTime":"0","summary":"Xenitra有限公司（XEN.AU）近日宣布完成对福康公司100%股权的收购，并同步取得运营非处方药（OTC）业务的关键资产。此次交易标志着该公司正式拓展医药健康领域，通过整合福康现有资源构建完整的非处方药产业链。资产包涵盖生产资质、销售渠道及品牌使用权等核心要素，为Xenitra在快速增长的自我药疗市场建立战略支点。此次收购将强化企业多元经营能力，预计通过协同效应提升整体竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XEN.AU","BK7128"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}